Ethosuximide Solution
NDC Package 59762-2350-7

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Ethosuximide solution is a medication used alone or with other medications to prevent and control a certain type of seizure (absence or petit mal seizure). This formulation utilizes a solution delivery system. Marketed by Mylan Pharmaceuticals Inc., this product is identified by NDC 59762-2350 and is authorized under FDA application ANDA080258.

Identification & Billing

NDC Package Code
59762-2350-7
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 474 mL in 1 BOTTLE, PLASTIC
Product Code
59762-2350
11-Digit Billing Format
59762235007
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ethosuximide
Non-Proprietary Name
Ethosuximide
Substance Name
Ethosuximide
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
ETHOSUXIMIDE 250 mg/5mL
Pharmacologic Class
Usage Information
This medication is used alone or with other medications to prevent and control a certain type of seizure (absence or petit mal seizure). It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.

Regulatory & Marketing

Labeler Name
Mylan Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA080258
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-21-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (59762-2350). Click a package code to view its specific billing and regulatory data.

59762-2350-6
1 BOTTLE, PLASTIC in 1 CARTON / 474 mL in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59762-2350-7 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 474 ml in 1 bottle, plastic of Ethosuximide, a human prescription drug labeled by Mylan Pharmaceuticals Inc.. This solution is formulated for oral use and contains ethosuximide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mylan Pharmaceuticals Inc. on February 21, 2020. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used alone or with other medications to prevent and control a certain type of seizure (absence or petit mal seizure). It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.

How is this Mylan Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59762235007. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
59762-2350-7
11-Digit CMS (5-4-2)
59762-2350-07

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.